Breast Cancer Clinical Program Archives - Page 22 of 27

Charles M. Perou, PhD, professor of genetics and pathology at the University of North Carolina School of Medicine and the basic science leader of the UNC Lineberger Comprehensive Cancer Center Breast Cancer Research Program, has been acknowledged as a health care innovator by the Triangle Business Journal. During an awards ceremony on Thursday, Perou was selected from a pool of candidates as the finalist in the 2015 TBJ Health Care Heroes – Innovator category.

UNC Lineberger member Melissa Troester, PhD, values a team approach in her work and her personal life. As co-leader of the cancer center’s Cancer Epidemiology Program, Troester’s work is an important part of UNC Lineberger’s interdisciplinary research on the causes of breast cancer and the translational research on strategies of prevention, treatment and cure.

Fayetteville resident Cathy Andrews felt the lump in her breast and immediately called her doctor. A mammogram and ultrasound later, she was escorted into another room to see the doctor. “When they start drawing and measuring, you know something is wrong,” she says.

Nancy Graham, a member of the N.C. Cancer Hospital Patient and Family Advisory Board, says “this Board is a working Board, doing more and more to make a difference for the patients and families. We’re not a Board that sits and says hello to each other every two months. We’re actively involved in many aspects of the cancer hospital.”

For Rivka From and her daughters Carlye and Courtney, genetic testing at UNC provided them with “an opportunity to live an amazing life,” Rivka says.

After weighing the risk of serious side effects with the benefits of a breast cancer prevention drug, a study led by a University of North Carolina at Chapel Hill researcher found that the drug’s benefits outweighed risks for most, but not all women.

Researchers look at area around tumors to help personalize treatment for triple-negative breast cancer

UNC Lineberger members Lisa Carey, MD, Chuck Perou, PhD, Hyman Muss, MD, Carey Anders, MD, and Katherine Hoadley, PhD will present at leading breast cancer research symposium.

Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital, has been named to the American Society of Clinical Oncology (ASCO) Nominating Committee. An ASCO member since 1997, Carey will serve a three-year term on the committee.

Marc Hurlbert, Avon Foundation Breast Cancer Crusade executive director presents a ceremonial check for $200,000 to Hazel Nichols, PhD

The 12th annual Avon Walk for Breast Cancer season concluded with the Charlotte Walk on October 26, raising $1.4 million to accelerate breast cancer research and improve access to screening, diagnosis, treatment and education. Hazel Nichols, PhD, assistant professor epidemiology at UNC Gillings School of Global Public Health is leading one of five teams in the Carolinas awarded a grant of $200,000 to support a study that will analyze data from 18 ongoing studies on pregnancy-associated breast cancer.

Tag: Breast Cancer Clinical Program

Perou recognized as health care innovator, awarded Triangle Business Journal honor

Melissa Troester, PhD – Team Science at its Best

Cathy Andrews

Nancy Graham

Rivka From

Breast cancer prevention drug benefit varies among at-risk women, study finds

Tumor microenvironment is a rough neighborhood for nanoparticle cancer drugs

UNC Lineberger members present at 2014 San Antonio Breast Cancer Symposium

Carey named newly elected member of ASCO Nominating Committee

Nichols awarded $200,000 Avon grant to study pregnancy-associated breast cancer